TP53 and nonpapillary renal cell carcinoma: Bishoy A et.al examined the expression of p16, p21, p27, p53 and p57 in a large cohort of patients in ccRCC treated with extirpative therapy, and found that p57 was the most common altered marker, altered in 60% of 452 patients [35].